FR2801508B1 - Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee - Google Patents

Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee

Info

Publication number
FR2801508B1
FR2801508B1 FR9914998A FR9914998A FR2801508B1 FR 2801508 B1 FR2801508 B1 FR 2801508B1 FR 9914998 A FR9914998 A FR 9914998A FR 9914998 A FR9914998 A FR 9914998A FR 2801508 B1 FR2801508 B1 FR 2801508B1
Authority
FR
France
Prior art keywords
seborrhea
treatment
reductase inhibitors
hmg coa
hmg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9914998A
Other languages
English (en)
Other versions
FR2801508A1 (fr
Inventor
Maria Dalko
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR9914998A priority Critical patent/FR2801508B1/fr
Priority to PCT/FR2000/003288 priority patent/WO2001039770A1/fr
Priority to AU21777/01A priority patent/AU2177701A/en
Publication of FR2801508A1 publication Critical patent/FR2801508A1/fr
Application granted granted Critical
Publication of FR2801508B1 publication Critical patent/FR2801508B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9914998A 1999-11-29 1999-11-29 Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee Expired - Fee Related FR2801508B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9914998A FR2801508B1 (fr) 1999-11-29 1999-11-29 Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee
PCT/FR2000/003288 WO2001039770A1 (fr) 1999-11-29 2000-11-24 UTILISATION D'INHIBITEURS D'HMG CoA-REDUCTASE POUR LE TRAITEMENT DE LA SEBORRHEE
AU21777/01A AU2177701A (en) 1999-11-29 2000-11-24 Use of hmg-coa reductase inhibitors for treating seborrhea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9914998A FR2801508B1 (fr) 1999-11-29 1999-11-29 Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee

Publications (2)

Publication Number Publication Date
FR2801508A1 FR2801508A1 (fr) 2001-06-01
FR2801508B1 true FR2801508B1 (fr) 2003-11-14

Family

ID=9552650

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9914998A Expired - Fee Related FR2801508B1 (fr) 1999-11-29 1999-11-29 Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee

Country Status (3)

Country Link
AU (1) AU2177701A (fr)
FR (1) FR2801508B1 (fr)
WO (1) WO2001039770A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4630065B2 (ja) * 2002-09-20 2011-02-09 興和株式会社 外用剤
FR2868309B1 (fr) * 2004-04-02 2006-05-26 Oreal Utilisation cosmetique d'au moins un inhibiteur d'hmg-coa-reductase comme agent destine a prevenir et/ou lutter contre les rides d'expression
SI2018153T1 (sl) 2006-04-26 2012-08-31 Rosemont Pharmaceuticals Ltd Tekoči oralni sestavki

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021451A (en) * 1988-11-14 1991-06-04 Hoffman-La Roche Inc. Method for inhibiting hyperproliferative diseases
JPH04193836A (ja) * 1990-11-26 1992-07-13 Banyu Pharmaceut Co Ltd 抗高脂血症剤
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
EP0738510A3 (fr) * 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
AU1593797A (en) * 1996-01-23 1997-08-20 Novartis Ag Use of fluvastatin derivatives in skin disease and topical compositions containing them

Also Published As

Publication number Publication date
FR2801508A1 (fr) 2001-06-01
AU2177701A (en) 2001-06-12
WO2001039770A1 (fr) 2001-06-07

Similar Documents

Publication Publication Date Title
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
MA26790A1 (fr) Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
NO974821L (no) Anvendelse av <alfa>1L-antagonister for behandling av urininkontinens
MA26822A1 (fr) Composes pour le traitement d'une ischemie.
FR2785521B1 (fr) Dispositif de suspension pour le traitement de prolapsus et d'incontinences urinaires
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
DE60044625D1 (de) Système d'assistance de conduire pour vehicules
MA26914A1 (fr) Derives bicycliques substitues pour le traitement d'une croissance cellulaire anormale
DE69731674T8 (de) Silencieux d'aspiration pour compresseur
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR13C0044I2 (fr) Utilisation de dihydroimidazolones pour le traitement de l'epilepsie canine
MA24332A1 (fr) Utilisation de 1-hydroxy-2- pyridones pour le traitement d'infections de la peau
FR2741262B1 (fr) Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
FR2771727B1 (fr) Defluoruration d'eaux usees
FR2746658B1 (fr) Valve de drainage implantable pour le traitement de l'hydrocephalie
FR2810547B1 (fr) Utilisation d'acides en c2-c10 pour la prevention des infections a bacteries a gram negatif
FR2801508B1 (fr) Utilisation d'inhibiteurs d'hmg coa-reductase pour le traitement de la seborrhee
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
MA23837A1 (fr) Benzamides pour le traitement de degenerescenses neurologiques
FR2737110B1 (fr) Utilisation d'acides monocarboxyliques pour le traitement des matieres keratiniques
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
FR2751637B1 (fr) Cellule d'electrocoagulation pour le traitement d'effluents
MA24831A1 (fr) Procede pour la preparation d'acides hydroxamiques
FR2818150B1 (fr) Composition pour le traitement d'objets destines a etre desinfectes

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20080930